STOCK TITAN

Rockwell Medical to Present at Noblecon18 Investor Conference

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Rockwell Medical, a biopharmaceutical company focused on iron deficiency and anemia treatment, will present at the Noblecon18 Annual Investor Conference on April 21, 2022, at 10:00 AM ET in Hollywood, Florida. A video webcast will be available the next day on the Rockwell Medical website and will remain archived for 90 days. Rockwell Medical is known for its Ferric Pyrophosphate Citrate platform and offers FDA-approved solutions for patients on hemodialysis, alongside plans to expand into home infusion settings.

Loading...
Loading translation...
Argus Session date unavailable
-3.61% session move Open Argus
Details

News Market Reaction – RMTI

The recorded move for RMTI in the trading session of this news was -3.61%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WIXOM, Mich., April 20, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients, today announced that the company is scheduled to present at the Noblecon18, Noble Capital Market's 18th Annual Investor Conference in Hollywood, Florida, on Thursday, April 21st at 10:00 AM ET.

A video webcast of the presentation will be available the following day on the Rockwell Medical website. The webcast will be archived on the company's website, the NobleCon website and on Channelchek.com for 90 days following the event.

About Rockwell Medical

Rockwell Medical is a commercial-stage biopharmaceutical company developing and commercializing its next-generation parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC), which has the potential to lead transformative treatments for iron deficiency in multiple disease states, reduce healthcare costs and improve patients' lives. The Company has two FDA-approved therapies indicated for patients undergoing hemodialysis, which are the first two products developed from the FPC platform. Rockwell Medical is also seeking to advance its FPC platform by developing FPC for the treatment of iron deficiency anemia in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting. In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States. For more information, visit www.RockwellMed.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/rockwell-medical-to-present-at-noblecon18-investor-conference-301528774.html

SOURCE Rockwell Medical Technologies, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Rockwell Medical scheduled to present at Noblecon18?

Rockwell Medical will present on April 21, 2022, at the Noblecon18 Annual Investor Conference.

When is the Noblecon18 Investor Conference taking place?

The Noblecon18 Investor Conference is scheduled for April 21, 2022.

At what time will Rockwell Medical's presentation occur?

Rockwell Medical's presentation will be at 10:00 AM ET.

Where can I watch Rockwell Medical's presentation?

The presentation will be available via a video webcast on the Rockwell Medical website the day after the event.

How long will the webcast of Rockwell Medical's presentation be available?

The webcast will be archived for 90 days following the event.

What is the focus of Rockwell Medical's biopharmaceutical developments?

Rockwell Medical focuses on transforming treatments for iron deficiency and managing anemia.

Keep reading